ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,367, issued on April 21.

"Methods of treatment and/or prevention of disorders and symptoms related to BKCa and/or SK channelophathies" was invented by Susanna Pietropaolo (Bordeaux, France), Wilhelmus Crusio (Pompignac, France), Valerie Lemaire (Birac, France) and Eric Louette (Rueil-Malmaison, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds and compositions for use in a method of treating and/or preventing neurological or non-neurological channelopathies, i.e., pathologies which are caused specifically by defects in some of the calcium-activated potassium channels. Specific neurological channelopath...